Fulcrum Insights/No Surprises Act & IDR Advisory

Winning the QPA Dispute

The Qualifying Payment Amount is the plan’s number, not the final one. For hospital-based groups, a disciplined federal IDR program turns a contested anchor into defensible payment.

For hospital-based groups — emergency medicine, radiology, anesthesiology, pathology — the No Surprises Act moved a large share of out-of-network payment into a federal arbitration whose anchor, the Qualifying Payment Amount, is set by the plan. Understanding that the QPA is a starting point rather than a ceiling is the difference between accepting a deflated rate and winning a defensible one.

Published
August 2026
Specialty
Hospital-Based Providers
Practice
NSA / IDR Advisory
Read
9 minutes

The QPA is the payer’s number — not the last word

The Qualifying Payment Amount is, in effect, the plan’s median contracted rate for the service in the market. Because the plan calculates it, providers have argued it can be depressed — for instance by including rarely used or ghost rates — and much of the early litigation over the NSA turned on how heavily arbitrators must weight it.

Providers have largely prevailed in those challenges: courts have reduced the QPA’s mandated primacy and required IDR entities to weigh the provider’s offer and other permitted factors, including prior contracted rates, acuity, and complexity. The result shows in the outcomes. Through the first half of 2024, providers prevailed in roughly 80% of federal payment determinations, and the share they won climbed from about 68% in early 2023 to roughly 85% by early 2024.

~80%
Share of federal IDR determinations won by providers, 2023–H1 2024 (Peterson-KFF)
6885%
Growth in provider win share from Q1 2023 to Q1 2024
~2×
Median anesthesia determination relative to QPA through mid-2024
$15
Per-party IDR administrative fee under the 2026 operations rule, down from $115
The Fulcrum Thesis

Winning IDR is not luck and it is not a single clever argument. It is a repeatable program: scrutinize the QPA, build the offer on evidence the arbitrator is required to weigh, and run the workflow at volume with disciplined economics. Groups that treat each dispute as bespoke leave both wins and dollars on the table.

A repeatable federal IDR workflow

The same sequence, applied to every eligible claim, is what converts a favorable legal environment into consistent recoveries.

  1. Confirm eligibility and the clock

    Verify NSA applicability, exhaust open negotiation, and track the tight IDR initiation windows.

  2. Interrogate the QPA

    Test the plan’s number for methodology weaknesses — ghost rates, wrong market, stale data — and document the challenge.

  3. Build the offer on weighted factors

    Support the offer with prior contracted rates, acuity, complexity, and training/scope — the evidence arbitrators must consider.

  4. Package for the arbitrator

    Assemble a clean, consistent evidentiary submission that makes the provider offer the reasonable choice.

  5. Operate at volume

    Run the program continuously, track outcomes by payer and region, and feed results back into strategy.

Why the economics just changed

The 2026 Federal IDR Operations rule cut the administrative fee to $15 per party per dispute, from $115, and expanded batching. That collapses the cost floor that once made lower-dollar hospital-based claims uneconomic to dispute — widening the set of claims where IDR is now rational and making program scale, not claim size, the constraint.

A favorable environment still rewards a disciplined program.

Providers are winning federal IDR — but the win rate reflects preparation as much as precedent. Arbitrators are required to weigh the provider’s offer and factors beyond the QPA; the groups that consistently prevail are the ones that supply that evidence in a clean, repeatable submission rather than improvising claim by claim.

With the administrative fee cut sharply and batching expanded under the 2026 operations rule, the economics now favor scale. The binding constraint is no longer the per-claim cost; it is whether a group has a program capable of running eligible disputes end to end. That is a build worth making deliberately.

Sources

  1. Peterson-KFF Health System Tracker, “The performance of the federal independent dispute resolution process through mid-2024” (May 2025).
  2. Georgetown Center on Health Insurance Reforms, “Independent Dispute Resolution Process 2024 Data: High Volume, More Provider Wins.”
  3. CMS, Federal Independent Dispute Resolution Operations Final Rule (2026) — administrative fee and batching changes; CMS fact sheet.
  4. Fulcrum Health Partners analysis and IDR program methodology.
How Fulcrum Helps

Related capabilities

Turn a QPA you can challenge into a payment you can win.

Fulcrum Health Partners builds repeatable federal IDR programs for hospital-based groups — QPA scrutiny, offer strategy, and evidence packaging designed to hold up before the arbitrator.

About this article. This Insight reflects Fulcrum Health Partners' analysis of publicly available information as of August 2026. Frameworks and any illustrative figures are Fulcrum analysis and not market benchmarks; illustrative calculations are not market benchmarks. Nothing herein is legal, financial, or valuation advice; specific regulations, coding rules, and contract terms should be reviewed with qualified counsel or a certified coder. © 2026 Fulcrum Health Partners. All rights reserved.

Back to all Insights